Wanjia Group Holdings Limited (HKG:0401)

Market Cap	61.62M
Revenue (ttm)	163.70M
Net Income (ttm)	-8.58M
Shares Out	560.22M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,200
Average Volume	207,382
Open	0.1090
Previous Close	0.1100
Day's Range	0.1090 - 0.1100
52-Week Range	0.0490 - 0.1820
Beta	1.32
RSI	50.93
Earnings Date	Feb 16, 2026

About Wanjia Group Holdings

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloo...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2004
• Employees: 180
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0401

Financial Performance

In 2024, Wanjia Group Holdings's revenue was 161.69 million, a decrease of -10.71% compared to the previous year's 181.09 million. Losses were -6.62 million, -83.45% less than in 2023.